A
Agios Pharmaceuticals, Inc. (AGIO)
NMS – Real vaqt narxi. Valyuta: USD
28.42
+0.43 (1.54%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
28.42
+0.43 (1.54%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Agios Pharmaceuticals, Inc., biotexnologiya kompaniyasi, Qo'shma Shtatlarda hujayra metabolizmi sohasida dori-darmonlarni ishlab chiqadi va rivojlantiradi. Uning asosiy mahsuloti PYRUKYND (mitapivat) bo'lib, u yovvoyi turdagi va mutatsiyaga uchragan piruvat kinaza (PK) ning faollashtiruvchisi, bu fermentlar PK etishmovchiligi bo'lgan kattalardagi gemolitik anemiyalarni davolash uchun ishlatiladi. Kompaniyaning PYRUKYND mahsuloti, shuningdek, 3-bosqichli klinik sinovda bo'lgan o'roq hujayrali anemiya; bolalarda PK etishmovchiligini davolash; va AQVESME alfa- yoki beta-talassemiyasi bo'lgan bemorlarni davolash uchun ishlatiladi. Bundan tashqari, kompaniya tebapivatni ishlab chiqdi, bu past xavfli mielodisplastik sindrom va o'roq hujayrali anemiya uchun PK faollashtiruvchisi; AG-181, fenilketonuriya (PKU) ni davolash uchun fenilalanin gidroksilaza stabilizatori; va AG-236, Alnylamdan litsenziyalangan siRNA, transmembrane serine protease 6 (TMPRSS6) geniga yo'naltirilgan bo'lib, polisitemiya verani davolash uchun. Agios Pharmaceuticals, Inc. 2007 yilda tashkil etilgan va shtab-kvartirasi Kembrijda, Massachusets shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Craig B. Thompson M.D. | Co-Founder |
| Dr. Krishnan Viswanadhan M.B.A., Pharm.D. | Chief Corporate Development & Strategy Officer |
| Dr. Lewis clayton Cantley Ph.D. | Co-Founder |
| Dr. Sarah Gheuens M.D., Ph.D. | Chief Medical Officer and Head of Research & Development |
| Dr. Shin-San Su Ph.D. | Co-Founder |
| Dr. Tak Wah Mak D.Sc., FRSC, Ph.D. | Co-Founder |
| Mr. Brian M. Goff M.B.A. | CEO & Director |
| Mr. James William Burns | Chief Legal Officer |
| Mr. T. J. Washburn | VP, Controller & Principal Accounting Officer |
| Ms. Cecilia Jones | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-29 | 8-K | agio-20260429.htm |
| 2026-04-29 | 10-Q | agio-20260331.htm |
| 2026-04-24 | DEFA14A | d110886ddefa14a.htm |
| 2026-04-24 | ARS | d923530dars.pdf |
| 2026-02-12 | 10-K | agio-20251231.htm |
| 2026-01-12 | 8-K | agio-20260112.htm |
| 2025-10-30 | 10-Q | agio-20250930.htm |
| 2025-08-04 | 8-K | agio-20250804.htm |
| 2025-07-31 | 10-Q | agio-20250630.htm |
| 2025-07-08 | 8-K | agio-20250703.htm |